Table 3.

Adverse events (AEs)

	CS1002 N=83	Simple linctus N=79
AEs, n (%)	Total N (%)	Total N (%)
Number of participants with an AE	17 (20.5)	21 (27.6)
Nervous system disorders	7 (8.4)	10 (13.2)
Headache	5 (6.0)	9 (11.8)
Dizziness	1 (1.2)	2 (2.6)
Respiratory, thoracic and mediastinal disorders	8 (9.6)	9 (11.8)
Oropharyngeal pain	2 (2.4)	4 (5.3)
Cough	2 (2.4)	3 (3.9)
Productive cough	3 (3.6)	1 (1.3)
Dyspnoea	0 (0.0)	2 (2.6)
Gastrointestinal disorders	5 (6.0)	2 (2.6)
Diarrhoea	3 (3.6)	0 (0.0)
Abdominal pain upper	2 (2.4)	0 (0.0)
General disorders and administration site conditions	0 (0.0)	5 (6.6)
Pain	0 (0.0)	3 (3.9)
Fever	0 (0.0)	2 (2.6)
Infections and infestations	1 (1.2)	2 (2.6)
Lower respiratory tract infection	0 (0.0)	2 (2.6)

Treated set population. AEs reported for >1 participant.